piracetam has been researched along with cardiovascular agents in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grosse, G; Lindner, G; Plonka, G | 1 |
| Autuori, A; Belcastro, V; Calabresi, P; Costa, C; Galletti, F; Parnetti, L; Pierguidi, L; Pisani, F | 1 |
| Czuczwar, SJ; Lukawski, K; Raszewski, G | 1 |
1 trial(s) available for piracetam and cardiovascular agents
| Article | Year |
|---|---|
Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational study.
Topics: Aged; Aged, 80 and over; Aggression; Anticonvulsants; Brain Ischemia; Cardiovascular Agents; Drug Interactions; Epilepsy; Female; Fibrinolytic Agents; Gait Ataxia; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Sleep Stages | 2008 |
2 other study(ies) available for piracetam and cardiovascular agents
| Article | Year |
|---|---|
[The effects of certain psycho- and coronary therapeutic agents on nerve tissue in vitro].
Topics: Animals; Cardiovascular Agents; Cells, Cultured; Dipyridamole; Ganglia; Hippocampus; Meclofenamic Acid; Nerve Tissue; Piracetam; Prenylamine; Psychotropic Drugs; Rats | 1978 |
Interactions between levetiracetam and cardiovascular drugs against electroconvulsions in mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticonvulsants; Avoidance Learning; Cardiovascular Agents; Disease Models, Animal; Diuretics; Dose-Response Relationship, Drug; Drug Interactions; Electroshock; Injections, Intraperitoneal; Levetiracetam; Mice; Piracetam; Seizures | 2014 |